Publications (18) Almudena Navarro Bailón publications

filter_list

2025

  1. Generation and GMP scale-up of human CAR-T cells using non-viral Sleeping Beauty transposons for B cell malignances

    Molecular Therapy Methods and Clinical Development, Vol. 33, Núm. 1

  2. GvHD prophylaxis with tacrolimus, sirolimus, and mycophenolate mofetil after reduced intensity conditioning hematopoietic stem cell allogeneic transplantation

    Bone Marrow Transplantation

  3. Tonic signaling of the B-cell antigen-specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages

    Molecular Oncology

2024

  1. Proteogenomics & Immunopeptidomics guided the molecular classification of Chronic Lymphocytic Leukemia for peptide based immunotherapy

    IX Congress of the Spanish Proteomics Society

  2. Quantifying HLA Mismatches at Epitope Level in Haplo-HSCT: Impact in the Outcome in Strategies Using PTCy

    HLA, Vol. 104, Núm. 5

  3. Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL

    HemaSphere

  4. Treatment of post-allogeneic hematopoietic stem cell transplant cytopenias with sequential doses of multipotent mesenchymal stromal/stem cells

    Cytotherapy, Vol. 26, Núm. 8, pp. 806-812

2023

  1. Effects of Dietary Supplementation with a Ferulic Acid-Rich Bioactive Component of Wheat Bran in a Murine Model of Graft-Versus-Host Disease

    Nutrients, Vol. 15, Núm. 21

  2. IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia

    Blood Advances

  3. Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY

    eClinicalMedicine, Vol. 65

  4. Systematic Evaluation of Antigenic Stimulation in Chronic Lymphocytic Leukemia: Humoral Immunity as Biomarkers for Disease Evolution

    Cancers, Vol. 15, Núm. 3

2022

  1. Eltrombopag increases the hematopoietic supporting ability of mesenchymal stem/stromal cells

    Therapeutic Advances in Hematology, Vol. 13

  2. Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia

    Molecular Cancer, Vol. 21, Núm. 1

  3. Unravelling soluble immune checkpoints in chronic lymphocytic leukemia: Physiological immunomodulators or immune dysfunction

    Frontiers in Immunology, Vol. 13

2021

  1. Co-administration of human MSC overexpressing HIF-1α increases human CD34+ cell engraftment in vivo

    Stem Cell Research and Therapy, Vol. 12, Núm. 1

  2. Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia (AML)

    Blood

2020

  1. Short tandem repeats (STRS) as biomarkers for the quantitative follow-up of chimerism after stem cell transplantation: Methodological considerations and clinical application

    Genes, Vol. 11, Núm. 9, pp. 1-18

2019

  1. Exportin-1 E571K mutation is a common finding in patients with classical Hodgkin lymphoma

    Hematological Oncology